Worried about your State Pension income? Here are 2 FTSE 100 dividend stocks I’d buy today

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver improving income returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the State Pension amounting to just £8,767 per year, many retirees are likely to need a second income in older age.

Since the FTSE 100 appears to offer good value for money at the present time, with it having a dividend yield of around 4.5%, there are a number of opportunities to generate a growing passive income across the large-cap share universe.

With that in mind, here are two FTSE 100 stocks that could offer an improving income outlook, as well as relatively stable financial performance over the long term.

AstraZeneca

It’s been a difficult journey for pharmaceutical company AstraZeneca (LSE: AZN) over the last decade. It has seen its profitability fall heavily due to the loss of patents on key drugs, with this leading to a lack of dividend growth in recent years.

Now though, the company appears to be in a relatively strong position. It has invested heavily in its pipeline under a strategy that has sought to focus on core growth areas. This strategy is now expected to bear fruit, with the business forecast to post a rise in net profit of around 12% in the current year.

This could stimulate AstraZeneca’s dividend growth prospects, and lead to an improving income outlook for its investors. It now has a dividend yield of just 3.4%, but its potential to increase dividends at a pace that exceeds inflation could lead to a robust outlook from an income perspective.

Alongside this, the company’s defensive appeal could help it to outperform the wider FTSE 100 at a time when the prospects for the global economy remain highly uncertain.

Unilever

Unilever’s (LSE: ULVR) recent updates have shown that its current growth strategy is paying off. It has focused investment on fast-growing markets across the emerging world, with them now making up the lion’s share of its revenue. They are also the main catalyst behind the company’s growth rate, and are likely to remain so over the medium term as wages in countries such as China move higher at a rapid rate.

Like AstraZeneca, Unilever’s dividend yield is below that of the wider FTSE 100 at the present time. The consumer goods company is set to record an income return of just 2.9% in the current year. However, with its bottom line forecast to produce a gain of 10% this year and its dividend payments being covered 1.6 times by profit, the scope for a rapidly-rising dividend seems to be high.

Although Unilever may lack the defensive appeal of some of its FTSE 100 peers, its potential to enjoy above-average growth over the long run seems to be high. It has a wide range of popular brands in a number of different markets. This provides it with a wide economic moat which, alongside its growth potential, makes it an enticing income opportunity for the long term.

Peter Stephens owns shares of AstraZeneca and Unilever. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Growth Shares

2 of the cheapest FTSE 100 stocks to consider buying as we hit 2026

Jon Smith calls out a couple of FTSE 100 companies that have fallen in the past year that he believes…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

Why Tesla stock outperformed the S&P 500 — again — in 2025

As the Tesla share price shrugs off declining revenues and profits to climb 19%, what kind of further excitement will…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Thinking of investing in the stock market? Keep these basic rules in mind

Investing in the stock market can put investors on the fast track to building wealth and earning passive income. And…

Read more »

piggy bank, searching with binoculars
US Stock

This Dow Jones stock could be a dark horse outperformer for 2026

Jon Smith looks across the pond and spots a Dow Jones company that has fallen by 11% in the past…

Read more »

Investing Articles

Why Greggs shares crashed 40% in 2025

Greggs has more stores than it had a year ago and total sales are higher, so is a 40% discount…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

4 pros and cons of buying Lloyds shares in 2026!

Investors piled into Lloyds shares last year as the bank delivered strong trading numbers in tough conditions. Could the FTSE…

Read more »

Investing Articles

Prediction: AI stocks will rise again in 2026 and Nvidia’s share price will soar to this level

Can Nvidia and other AI stocks continue to perform in 2026? Edward Sheldon believes so. Here, he explains why he’s…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

3 S&P 500 growth stocks that could make index funds looks silly over the next 5 years

Edward Sheldon believes these three high-flying S&P 500 stocks have the potential to smash the market over the next five…

Read more »